Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer.
Emerik OsterlundBengt GlimeliusPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Overall survival in Swedish patients with mCRC has improved during the past decade but is still substantially worse than reported from clinical trials/hospital-based series, reflecting the selection of patients to trials. Regional differences were seen, but they decreased with time. Women did not have a poorer prognosis in multivariable analyses.
Keyphrases
- metastatic colorectal cancer
- clinical trial
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- polycystic ovary syndrome
- prognostic factors
- mental health
- type diabetes
- metabolic syndrome
- adipose tissue
- patient reported outcomes
- skeletal muscle
- pregnant women
- pregnancy outcomes
- cervical cancer screening